The award bears the name of the person who founded medical oncology in Italy and contributed to changing the international panorama, that of “Gianni Bonadonna”, and was awarded in recent days by the Italian Association of Medical Oncology to Professor Francesco Cognetti. “I am honored to receive this recognition and I thank all the Aiom members of the trust – said the oncologist during the 25th annual Aiom congress which took place in the capital, during the awarding of the Award – When I embarked on a career as doctor, this specialization represented a challenge against a very difficult pathology, where the chances of success depended exclusively on our capacity for research and innovation”.
A long career
Today Cognetti is President of the Federation of Oncologists, Cardiologists and Hematologists (FOCE), coordinator of the “Forum of the Scientific Societies of Italian Hospital and University Clinicians”, professor of Medical Oncology at the UniCamillus International Medical University of Rome and Member of the Scientific Advisory Board of the Fatebenefratelli Isola Tiberina – Gemelli Hospital (with specific delegation to the development of Clinical Research in Oncology).
by Dario Rubino
In the past, he held the position of president of Aiom (from 2001 to 2003) and worked for 32 years as Director of Medical Oncology at the Regina Elena Institute in Rome. From 2001 to 2006 he was also Scientific Director and General Secretary of the “Alliance Against Cancer”, and from 1991 to 2001 Member of the Executive Committee of the European Society of Medical Oncology (ESMO). He is the author of approximately 450 scientific works published in important international journals. “It is important to remember – concluded Cognetti – that the goals achieved in recent years are the result of a correct development of communication and the exchange of information which has created a relationship that is not only professional but also personal and sincere towards colleagues, patients and their families. I hope to have contributed to the growth of clinical research in Medical Oncology both in Italy and internationally.”